000 02098cam  2200409zi 4500
0019.880145
003CaOODSP
00520221107165713
006m     o  d f      
007cr |||||||||||
008191003t20202020quc     ob   f000 0 eng d
020 |a9780660328263
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aEn14-392/2019E-PDF
24500|aScreening assessment : |bantimony-containing substances.
264 1|a[Gatineau, Quebec] : |bEnvironment and Climate Change Canada : |bHealth Canada, |c2020.
264 4|c©2020
300 |a1 online resource (v, 44 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"July 2020."
500 |aCover title.
500 |aIssued also in HTML format.
500 |aIssued also in French under title: Évaluation préalable : substances contenant de l’antimoine.
504 |aIncludes bibliographical references (pages 27-38).
520 |a"Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of 11 substances referred to collectively as the Antimony-containing Substances Group. Substances in this group were identified as priorities for assessment as they met categorization criteria under subsection 73(1) of CEPA"--Synopsis, page i.
650 0|aAntimony|xToxicology|zCanada.
650 0|aAntimony|xEnvironmental aspects|zCanada.
650 0|aAntimony|xHealth aspects|zCanada.
7101 |aCanada. |bEnvironment and Climate Change Canada, |eissuing body.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tÉvaluation préalable : |w(CaOODSP)9.880146
85640|qPDF|s827 KB|uhttps://publications.gc.ca/collections/collection_2021/eccc/en14/En14-392-2019-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/screening-assessment-antimony-containing-substances.html